Dr. Agarwal's Health Care Limited

Dr. Agarwal's Health Care Limited

Dr. Agarwal's Health Care Limited has announced the closure of its trading window for designated persons and their immediate relatives, effective from June 30, 2026. This action is taken in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015. The closure is specifically for the finalization and publication of the company's unaudited standalone and consolidated financial results for the quarter ending June 30, 2026. The trading window will reopen 48 hours after these financial results are publicly announced. This is a routine regulatory measure to prevent insider trading before crucial financial information is released to the market.

Dr. Agarwal's Health Care Limited

Dr. Agarwal's Health Care Limited announced a disclosure submitted under Regulation 31(4) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. This filing was made by several associated individuals and trusts, including Dr. Adil Agarwal, Dr. Amar Agarwal, and their respective family trusts. Regulation 31(4) mandates persons acting in concert (PACs) to disclose their aggregate shareholding and voting rights annually. This disclosure enhances transparency for investors, confirming the combined holdings of the identified promoter group and ensuring compliance with takeover regulations.